Home › Funds › Patient Square Capital LP › PCVX

Patient Square Capital LP position in PCVX

VAXCYTE INC · Health Care

Patient Square Capital LP reported holding 166,000 shares of PCVX (VAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 1.51% of its reported portfolio and ranking #18 among its reported holdings. Patient Square Capital LP first reported this position in Q3 2026.

Latest position (Q3 2026)166.00K sh
Reported value held$9.45M
Portfolio Weight1.51%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's PCVX position evolved

Patient Square Capital LP first disclosed a stake in PCVX in Q3 2026 at 166,000 shares (US$9.4M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 166.00K $9.45M New

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 33 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has Patient Square Capital LP held PCVX?

Patient Square Capital LP has disclosed PCVX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Patient Square Capital LP's current position in PCVX?

As of Q3 2026, Patient Square Capital LP holds 166.00K shares of PCVX (VAXCYTE INC), valued at $9.45M, representing 1.51% of its reported portfolio and ranking #18.

Has Patient Square Capital LP been buying or selling PCVX?

In the latest 13F filing (Q3 2026), Patient Square Capital LP newly opened its position in PCVX.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.